Chemed Corporation (CHE) vs Immunovant, Inc. (IMVT)
A side-by-side comparison of Chemed Corporation and Immunovant, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CHE
Chemed Corporation
$509.75HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
IMVT
Immunovant, Inc.
$31.97HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — CHE vs IMVT
growth of $100 · dividends reinvested · last 7yCHE +51.2% (+6.1%/yr)IMVT +234.2% (+18.8%/yr)IMVT compounded faster over this window
CHE IMVT
CHE vs IMVT: by the numbers
- •CHE is the larger company ($6.66B vs $6.60B market cap).
- •CHE is profitable (10.60% net margin) while IMVT runs a net loss (-7585.86%).
- •CHE pays a dividend (0.49% yield), while IMVT has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CHE | IMVT |
|---|---|---|
| P/E ratio | 25.59 | N/A |
| Forward P/E | 20.00 | N/A |
| P/S ratio | 2.57 | 929.90 |
| P/B ratio | 8.02 | 8.97 |
| EV / EBITDA | 16.73 | N/A |
| FCF yield | 4.86% | N/A |
Profitability
| Metric | CHE | IMVT |
|---|---|---|
| Gross margin | 30.44% | 0.00% |
| Operating margin | 13.46% | 0.00% |
| Net margin | 10.60% | -7585.86% |
| ROE | 33.11% | -73.19% |
| ROIC | 19.48% | -76.00% |
Dividends
| Metric | CHE | IMVT |
|---|---|---|
| Dividend yield | 0.49% | N/A |
| Payout ratio | 12.55% | N/A |
Growth (annualized)
| Metric | CHE | IMVT |
|---|---|---|
| Revenue CAGR (5Y) | 4.12% | N/A |
| EPS CAGR (5Y) | -1.65% | N/A |
| FCF CAGR (5Y) | -5.44% | N/A |
| Total return CAGR (5Y) | 3.58% | 29.93% |
Frequently asked
- Does CHE or IMVT pay a bigger dividend?
- CHE pays a dividend (0.49% yield), while IMVT has no payments in the available dividend history.
- Is CHE or IMVT more profitable?
- CHE runs the higher net margin — CHE at 10.60% versus IMVT at -7585.86%.
- How have CHE and IMVT total returns compared?
- Over the past 5 years, CHE delivered 3.58% and IMVT delivered 29.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Chemed P/E ratioChemed dividend yieldChemed ROEImmunovant ROEChemed operating marginImmunovant operating marginChemed revenue growthImmunovant revenue growthChemed free cash flowImmunovant free cash flow
Chemed & Immunovant appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.